What smart money is saying about Divi's Laboratories Limited
1 fund in our archive has pitched Divi's Laboratories Limited — most recently Baron Emerging Markets Fund in June 2026.
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
Get an email when a fund writes about it
Position history
Every position in Divi's Laboratories Limited on record in the archive was reported in Q2 2026, across 1 fund letter — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | 0 | 1 |
Fund activity · 1 position · 1 move
- AddedBaron India FundJune 2026
“Finally, we added to several of our existing positions during the quarter, most notably InterGlobe Aviation Limited , Bajaj Finance Limited , JSW Energy Limited , Acutaas Chemicals Limited , Nuvama Wealth Management Limited , Divi's Laboratories Limited , and Trent Limited .”
Read the letterDivi's Laboratories Limited
Fund coverage · 1 thesis
- Baron Emerging Markets FundJune 2026
Divi's Laboratories is a global APIs and intermediates manufacturer benefiting from supply-chain diversification, GLP-1 demand, and scalable manufacturing.
Read the full thesis
Read every full thesis on Divi's Laboratories Limited
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→